Mary K. Grizzle

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

Christopher Aquino, Duncan Armour, Judd Berman et al. · Journal of Medicinal Chemistry · 1996 · 101 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Glaxo Registry File +15

Optimization of 3-(1<i>H</i>-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Brad R. Henke, Christopher Aquino, Larry S. Birkemo et al. · Journal of Medicinal Chemistry · 1997 · 86 citations · Full text

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

Mikhail Kalinichev, Claire Rourke, Alex J. Daniels et al. · Psychopharmacology · 2005 · 71 citations

Obesity, Medicine, Physiology +8

Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.

Michael K. James, Ann M. Vuong, Mary K. Grizzle et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 65 citations

Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist

A.J. Daniels, Mary K. Grizzle, Robert P. Wiard et al. · Regulatory Peptides · 2002 · 59 citations

Obesity, Nutrition, Metabolic Syndrome +12